The Centers for Disease Control and Prevention (CDC) recommends that pregnant women receive an RSV vaccine during their third ...

Since the start of February, pregnant women have been eligible to get vaccinated against respiratory syncytial virus (RSV).  The vaccine is administered during the 28 to 36 week mark of pregnancy to ...

New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new drug that protects against RSV, a common cold-like virus that can cause ...

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

RSV has outstripped severe Covid and flu hospitalisation rates and proved itself more fatal than either of the flu season ...

Preliminary findings linking RSV and shingles vaccines to lower dementia risk are intriguing but not conclusive, local ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...